The role of the endothelial NPYR1-TRPC3-ET1 signaling axis in neurovascular coupling dysfunction

内皮NPYR1-TRPC3-ET1信号轴在神经血管耦合功能障碍中的作用

基本信息

  • 批准号:
    10667097
  • 负责人:
  • 金额:
    $ 38.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

This R01 application focuses on the underlying mechanisms of neurovascular coupling dysfunction. The brain consumes a large amount of energy which must be supplied as oxygen and glucose by blood flow. Neurovascular coupling, a mechanism that matches local neuronal activity to blood flow, is critical to maintain local microenvironment and normal brain function. However, normal neurovascular coupling is disrupted in seizure, traumatic brain injury, and other neurological disorders. Despite continued high neuronal metabolism, small cerebral arteries and arterioles begin to inappropriately constrict to limit CBF to the challenged neurons. This pathogenic vasoconstriction, termed the “inverse hemodynamic response” (IHR), is thought to contribute to brain damage and functional impairment in these neurological diseases. The mechanism of IHR is unknown. This proposal seeks to test a novel hypothesis that seizure-induced IHR is mediated by an endothelial signaling pathway consisted of Neuropeptide Y Receptor 1 (NPYR1), Transient Receptor Potential (Canonical) 3 (TRPC3) channels, and endothelin 1 (ET1). We generated inducible and brain-specific endothelial TRPC3 knockout line and NPYR1 knockout line. These novel mouse lines will be used in combination with NPYR1, TRPC3 and ET1 receptor selective inhibitors to test our hypothesis. Aim 1 will demonstrate the existence of an endothelial NPYR1-TRPC3-ET1 signaling pathway that mediates cerebral vasoconstriction using acutely isolated brain parenchymal arterioles and cranial window preparations in vivo. Aim 2 will show that the same signaling pathway mediates seizure-induced IHR. Aim 3 will determine whether disruption of this signaling pathway will reduce susceptibility to seizures and their deleterious consequences. The studies rely on complementary areas of expertise pooled by a research team with expertise in cerebrovascular reactivity, epilepsy and neuroinflammation and neurodegeneration. Collectively, these experiments will reveal new mechanistic insights regarding IHR and may lead to new treatments for epilepsy and other neurological diseases.
该R 01应用程序侧重于神经血管耦合功能障碍的潜在机制。大脑 消耗大量的能量,这些能量必须通过血流以氧气和葡萄糖的形式提供。神经血管 耦合是一种将局部神经元活动与血流相匹配的机制,对于维持局部神经元活动至关重要。 微环境和正常的大脑功能。然而,正常的神经血管耦合在癫痫发作中被破坏, 创伤性脑损伤和其他神经系统疾病。尽管持续的高神经元代谢, 脑动脉和小动脉开始不适当地收缩以限制CBF到达受攻击的神经元。这 致病性血管收缩,称为“逆血流动力学反应”(IHR),被认为有助于 这些神经系统疾病的脑损伤和功能障碍。《国际卫生条例》的机制尚不清楚。 该提议旨在验证一个新的假设,即糖尿病诱导的IHR是由内皮细胞信号转导介导的。 神经肽Y受体1(NPYR 1)、瞬时受体电位(经典)3(TRPC 3) 通道和内皮素1(ET 1)。我们构建了可诱导的脑特异性内皮TRPC 3敲除细胞系, 和NPYR 1敲除系。这些新的小鼠系将与NPYR 1、TRPC 3和ET 1组合使用 受体选择性抑制剂来验证我们的假设目的1将证明存在内皮细胞 利用急性离体脑介导脑血管收缩的NPYR 1-TRPC 3-ET 1信号通路 实质小动脉和颅窗制备体内。目标2将表明, 信号通路介导顺铂诱导的IHR。目的3将确定是否中断这一信号通路将 降低癫痫发作的易感性及其有害后果。这些研究依赖于互补领域 由一个在脑血管反应性、癫痫和 神经炎症和神经变性。总的来说,这些实验将揭示新的机制 这可能会导致癫痫和其他神经系统疾病的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FANG ZHENG其他文献

FANG ZHENG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FANG ZHENG', 18)}}的其他基金

Canonical Transient Receptor Potential Channels and Excitotoxicity
典型瞬时受体电位通道和兴奋性毒性
  • 批准号:
    7895102
  • 财政年份:
    2009
  • 资助金额:
    $ 38.6万
  • 项目类别:
Canonical Transient Receptor Potential Channels and Excitotoxicity
典型瞬时受体电位通道和兴奋性毒性
  • 批准号:
    7741176
  • 财政年份:
    2009
  • 资助金额:
    $ 38.6万
  • 项目类别:
METABOTROPIC GLUTAMATE RECEPTORS AND EXCITOTOXICITY
代谢型谷氨酸受体和兴奋性毒性
  • 批准号:
    7154744
  • 财政年份:
    2006
  • 资助金额:
    $ 38.6万
  • 项目类别:
METABOTROPIC GLUTAMATE RECEPTORS AND EXCITOTOXICITY
代谢型谷氨酸受体和兴奋性毒性
  • 批准号:
    7034897
  • 财政年份:
    2006
  • 资助金额:
    $ 38.6万
  • 项目类别:
ZINC-DEPENDENT APPARENT DESENSITIZATION OF NMDA RECEPTOR
NMDA 受体锌依赖性表观脱敏
  • 批准号:
    7405411
  • 财政年份:
    2000
  • 资助金额:
    $ 38.6万
  • 项目类别:
ZINC-DEPENDENT APPARENT DESENSITIZATION NMDA RECEPTORS
锌依赖性表观脱敏 NMDA 受体
  • 批准号:
    6394279
  • 财政年份:
    2000
  • 资助金额:
    $ 38.6万
  • 项目类别:
ZINC-DEPENDENT APPARENT DESENSITIZATION NMDA RECEPTORS
锌依赖性表观脱敏 NMDA 受体
  • 批准号:
    6195400
  • 财政年份:
    2000
  • 资助金额:
    $ 38.6万
  • 项目类别:
ZINC-DEPENDENT APPARENT DESENSITIZATION OF NMDA RECEPTOR
NMDA 受体锌依赖性表观脱敏
  • 批准号:
    7810647
  • 财政年份:
    2000
  • 资助金额:
    $ 38.6万
  • 项目类别:
ZINC-DEPENDENT APPARENT DESENSITIZATION NMDA RECEPTORS
锌依赖性表观脱敏 NMDA 受体
  • 批准号:
    6639611
  • 财政年份:
    2000
  • 资助金额:
    $ 38.6万
  • 项目类别:
ZINC-DEPENDENT APPARENT DESENSITIZATION OF NMDA RECEPTOR
NMDA 受体锌依赖性表观脱敏
  • 批准号:
    7612079
  • 财政年份:
    2000
  • 资助金额:
    $ 38.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了